Skip to main content

Table 2 Clinical characteristics of patients with CKD 3 and 4

From: Cognitive impairment and depression in a population of patients with chronic kidney disease in Colombia: a prevalence study

Clinical characteristics

Cognitive impairment no

Cognitive impairment yes

Total

p value

(n = 123)

(n = 128)

(n = 251)

Previous medical history, n (%)

       

 High blood pressure (HBP)

       

  Slight HBP

81

(65.9)

75

(58.6)

156

(62.2)

0.606

  Moderate HBP

20

(16.3)

23

(18.0)

43

(17.1)

  Severe HBP

3

(2.4)

5

(3.9)

8

(3.2)

  Without HBP

19

(15.4)

25

(19.5)

44

(17.5)

 Diabetes mellitus, n (%)

29

(23.6)

31

(24.2)

60

(23.9)

0.905

 Hypothyroidism, n (%)

34

(27.6)

41

(32.0)

75

(29.9)

0.377

 Stroke, n (%)

10

(8.1)

12

(9.4)

22

(8.8)

0.742

 Smoking, n (%)

33

(26.8)

35

(27.3)

68

(27.1)

0.927

 Anemia, n (%)

4

(3.1)

4

(1.6)

 Sedentary lifestyle, n (%)

64

(52.0)

72

(56.3)

136

(54.2)

0.417

 Alcohol consumptionb, n (%)

8

(6.5)

6

(4.7)

14

(5.6)

0.541

 Glomerular filtration rate, ml/min, median (IQR)

44

(37–49)

39.5

(31–48)

42

(34–48)

0.028

  Stage 3 chronic kidney disease, n (%)

110

(89.4)

107

(83.6)

217

(86.5)

0.177

  Stage 4 chronic kidney disease, n (%)

13

(10.6)

21

(16.4)

34

(13.5)

Cause of kidney disease, n (%)

       

  Diabetes

21

(17.1)

27

(21.1)

48

(19.1)

0.750

  HBP

89

(72.4)

81

(63.3)

170

(67.7)

  Glomerulonephritis

1

(0.8)

4

(3.1)

5

(2.0)

  Obstructive condition

6

(4.9)

10

(7.8)

16

(6.4)

  Unknown

6

(4.9)

6

(4.7)

12

(4.8)

 Body mass index, kg/mt2, median (IQR)a

24

(23–27)

25

(22–27)

25

(23–27)

0.908

  Normal

58

(47.5)

60

(49.2)

118

(48.4)

0.726

  Overweight

53

(43.4)

48

(39.3)

101

(41.4)

  Obese

11

(9.0)

14

(11.5)

25

(10.2)

  1. IQR interquartile range
  2. aData were available for 244 patients
  3. bWorld Health Organization criteria